Bio Protocol vs Polymesh — how do they compare? Bio Protocol trades at Rp512.02 (market cap Rp1,15T, Rp256,3M 24h volume), while Polymesh trades at Rp642.18 (market cap Rp699,51M, Rp22,08M 24h volume). The key difference: Bio Protocol is far larger — about 1644× Polymesh's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Polymesh's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Polymesh for 20 Days on average.
| BIO | POLYX | |
|---|---|---|
Market Cap | Rp1,15T | Rp699,51M |
Volume (24h) | Rp256,3M | Rp22,08M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1,1B POLYX |
Typical Hold Time | 16 Days | 20 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →POLYX is the native protocol token of Polymesh, an institutional-grade permissioned blockchain built specifically for regulated assets. It streamlines antiquated processes and opens the door to new financial instruments by solving challenges with public infrastructure around governance, identity, compliance, confidentiality, and settlement. The token can be used to stake and secure the network, pay transaction fees, and engage in governance.
Read more on POLYX →